📚 Extracted Documents

This document is an order issued by the Ministry of Chemicals & Fertilizers, specifically addressing the review application by M/s Wipro GE Healthcare Pvt. Limited against NPPA notifications related to the pricing of Iohexol injections. The review petition was rejected as it was not submitted within the required timeframe as outlined in the Drugs (Prices Control) Order, 2013.

This document is an order issued by the Ministry of Chemicals & Fertilizers, Government of India, regarding a review application filed by M/s Piramal Pharma Limited under the Drugs (Prices Control) Order, 2013. The application contested the price fixation of Calamine Lotion by the National Pharmaceutical Pricing Authority, which was ultimately rejected. The document details the arguments presented and the decision process undertaken by the relevant authorities.

This is an official order issued by the Ministry of Chemicals & Fertilizers, Department of Pharmaceuticals, regarding a review application filed by Glenmark Pharmaceuticals against a price fixation order by the NPPA for Clotrimazole Cream 1%. The NPPA's decision to fix the ceiling price was upheld, and the application for review was rejected. The order was issued on October 24, 2024, by the Sr. Economic Adviser to the Government of India.

This document is a comprehensive report analyzing the industry-academia gap between NIPER institutions and pharmaceutical industries in India. It includes detailed surveys and analysis gathered from students, alumni, faculty, and industry experts, aiming to offer insights and recommendations on improving collaboration. The report discusses various aspects such as research facilities, academic curriculum, and entrepreneurship within NIPER institutions.

This document is a detailed report prepared by DATAWISE® for the National Minorities Development and Finance Corporation. It analyzes the impact of the Drugs (Price Control) Order, 2013 on medical devices in terms of availability and affordability for consumers and the industry. The report includes methodological details, primary data analysis, and recommendations based on findings.

This document is an analytical report prepared by the Department of Pharmaceuticals in India, focusing on the potential impacts of the 'patent cliff' between 2022 and 2030 on the pharmaceutical industry. It explores drug pricing methodologies and the opportunities for Indian generic pharmaceutical companies as certain drugs go off-patent. The report includes various analyses, including PESTEL and SWOT, to provide insight into market dynamics and challenges faced by Indian generic manufacturers.

This document is an assessment study conducted by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India, focused on upgrading National Institute of Pharmaceutical Education and Research (NIPER) institutions to improve their global ranking. It includes a detailed analysis of current trends, best practices, and gaps in the pharmaceutical education sector. The report contains recommendations for enhancements to meet the needs of the evolving pharmaceutical business in India.

This is a comprehensive study on the Indian Contract Research Organization (CRO) sector conducted by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India. It covers various aspects of the CRO industry including market dynamics, trends, and challenges, and provides a detailed analysis of different sectors within the industry. The document, prepared by Biovantis Healthcare Private Limited, is intended for informational purposes and includes profiles of some promising CROs in India.

This document is a report prepared by the Foundation for MSME Clusters (FMC), submitted to the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers, Government of India. It focuses on strategies to boost the Indian medical devices industry, including health infrastructure, market dynamics, cluster development, R&D, and international competition. The report provides a detailed analysis and recommendations for developing medical device manufacturing in India.

The document is a final report from the Centre for Market Research & Social Development detailing a survey of medical devices clusters in India, commissioned by the Department of Pharmaceuticals, Government of India. It aims to evaluate the contribution and infrastructure of these clusters, with the study gathering both primary and secondary data through stakeholder interviews and focus groups. Key findings include the identification and assessment of infrastructure within medical clusters across various states in India, noting both strengths and areas for improvement.

This document is the final report of a survey conducted by the Centre for Market Research & Social Development, commissioned by the Government of India's Department of Pharmaceuticals. It reviews the infrastructure, logistics framework, and efficiency of pharmaceutical clusters across India, providing key findings and recommendations to enhance cluster competitiveness. This comprehensive study offers a geographical analysis, examining micro, small, medium, and large-scale industries within these clusters.

This document appears to discuss strategic measures for leveraging the ASEAN Free Trade Agreement (FTA) and exploring trade potential between India and Middle Eastern countries, specifically concerning the pharmaceutical sector. The content implies a focus on economic and trade policies, potentially issued by an institution in New Delhi. The document lacks an explicit release date and detailed actionable items in the sampled pages.

This document is a Website Quality Certificate issued by the STQC for the Department of Pharmaceuticals, certifying that their website meets the requirements of the 2018 Guidelines for Indian Government Websites. The certificate, issued on 28 April 2023, is valid until 27 April 2026. It signifies compliance with the standards set in the Website Quality Manual.